Search Result "inclisiran"
Inclisiran. A New Kid on the New Block for Treating Hypercholesterolaemia
Journal: Current Vascular Pharmacology
Volume: 19 Issue: 5 Year: 2021 Page: 449-450
Author(s): Vasilios G. Athyros,Chrysoula Boutari,Konstantinos Imprialos,Michael Doumas
PCSK9 Inhibition-Based Therapeutic Approaches: An ImmunotherapyPerspective
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 6 Year: 2022 Page: 980-999
Author(s): Amirhossein Sahebkar,Suowen Xu,Matteo Pirro,Amir Abbas Momtazi-Borojeni
PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 23 Year: 2023 Page: 1802-1824
Author(s):
Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 4 Year: 2019 Page: 332-340
Author(s): Theodosios D. Filippatos,Angelos Liontos,Eliza C. Christopoulou,Moses S. Elisaf
Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 22 Issue: 10 Year: 2022 Page: 1018-1028
Author(s):
Pharmacology of PCSK9 Inhibitors: Current Status and Future Perspectives
Journal: Current Pharmaceutical Design
Volume: 24 Issue: 31 Year: 2018 Page: 3622-3633
Author(s): Aikaterini N. Tsouka,Constantinos C. Tellis,Alexandros D. Tselepis
Clinical Translation of Anti-aging Associated Genetics: Current Progress and Challenges
Journal: Current Aging Science
Volume: 14 Issue: 3 Year: 2021 Page: 181-190
Author(s): Yi Wang
Nanocarriers for Biologicals Delivery to Cardiovascular System
Ebook: Nanomedicinal Approaches Towards Cardiovascular Disease
Volume: 1 Year: 2021
Author(s): Fahima Dilnawaz
Doi: 10.2174/9789814998215121010011
PCSK9 and Inflammation: Their Role in Autoimmune Diseases, witha Focus on Rheumatoid Arthritis and Systemic Lupus Erythematosus
Journal: Current Medicinal Chemistry
Volume: 29 Issue: 6 Year: 2022 Page: 970-979
Author(s): Federico Carbone,Stefano Ministrini
Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 36 Year: 2021 Page: 7427-7445
Author(s): Adel Hajj Ali,Nour Younis,Rola Abdallah,Farah Shaer,Ali Dakroub,Mohammed Akli Ayoub,Rabah Iratni,Hadi Mohamad Yassine,Kazem Zibara,Alexander Orekhov,Ahmed Fawzy El-Yazbi,Ali H. Eid